The New Challenges of 'Designer Drugs'

The new challenges of 'designer drugs'
The list includes substances that induce dependence, cause excitement or depression of the central nervous system, trigger hallucinations or disorders in movement, in judgment, in behaviour, in perception or in mood, where there are reasons to believe … Read more on euronews

Self-harm warns of repeated suicide attempt risk in schizophrenia
medwireNews: Individuals who have attempted suicide and also have a history of self-harm should be thoroughly assessed for psychotic symptoms in order to prevent delayed treatment and the risk for repeated suicide attempts, say researchers … Read more on medwireNews

J&J to pay .2B to end drug-label and kickback probes
The resolution of the long-running case covers the marketing of the anti-psychotic drugs Risperdal and Invega and the heart drug Natrecor over several years. From 1999 through 2005, J&J … Last year, Britain's GlaxoSmithKline Plc agreed to pay $ 3 … Read more on